BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2968 related articles for article (PubMed ID: 24841135)

  • 1. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Land GA; Peterson LE; Musser JM
    Arch Pathol Lab Med; 2013 Sep; 137(9):1247-54. PubMed ID: 23216247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia.
    Wenzler E; Goff DA; Mangino JE; Reed EE; Wehr A; Bauer KA
    Diagn Microbiol Infect Dis; 2016 Jan; 84(1):63-68. PubMed ID: 26603136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Alone versus MALDI-TOF MS Combined with Real-Time Antimicrobial Stewardship Interventions on Time to Optimal Antimicrobial Therapy in Patients with Positive Blood Cultures.
    Beganovic M; Costello M; Wieczorkiewicz SM
    J Clin Microbiol; 2017 May; 55(5):1437-1445. PubMed ID: 28228491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia.
    Huang AM; Newton D; Kunapuli A; Gandhi TN; Washer LL; Isip J; Collins CD; Nagel JL
    Clin Infect Dis; 2013 Nov; 57(9):1237-45. PubMed ID: 23899684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Antimicrobial Stewardship and Molecular Rapid Diagnostic Tests on Antimicrobial Prescribing for Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Bloodstream Infection.
    Kunz Coyne AJ; Casapao AM; Isache C; Morales J; McCarter YS; Jankowski CA
    Microbiol Spectr; 2021 Oct; 9(2):e0046421. PubMed ID: 34704795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
    BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system.
    Box MJ; Sullivan EL; Ortwine KN; Parmenter MA; Quigley MM; Aguilar-Higgins LM; MacIntosh CL; Goerke KF; Lim RA
    Pharmacotherapy; 2015 Mar; 35(3):269-76. PubMed ID: 25809178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost Analysis of Implementing Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Plus Real-Time Antimicrobial Stewardship Intervention for Bloodstream Infections.
    Patel TS; Kaakeh R; Nagel JL; Newton DW; Stevenson JG
    J Clin Microbiol; 2017 Jan; 55(1):60-67. PubMed ID: 27795335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and clinical outcomes of multidrug-resistant, gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period.
    Folgori L; Livadiotti S; Carletti M; Bielicki J; Pontrelli G; Ciofi Degli Atti ML; Bertaina C; Lucignano B; Ranno S; Carretto E; Muraca M; Sharland M; Bernaschi P
    Pediatr Infect Dis J; 2014 Sep; 33(9):929-32. PubMed ID: 24642515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
    Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
    Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes.
    Costa Pde O; Atta EH; Silva AR
    J Pediatr (Rio J); 2015; 91(5):435-41. PubMed ID: 26057184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated alerts coupled with antimicrobial stewardship intervention lead to decreases in length of stay in patients with gram-negative bacteremia.
    Pogue JM; Mynatt RP; Marchaim D; Zhao JJ; Barr VO; Moshos J; Sunkara B; Chopra T; Chidurala S; Kaye KS
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):132-8. PubMed ID: 24442074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital.
    Hwang H; Kim B
    Sci Rep; 2018 Oct; 8(1):14757. PubMed ID: 30283084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control analysis of endemic Acinetobacter baumannii bacteremia in the neonatal intensive care unit.
    Hsu JF; Chu SM; Lien R; Chiu CH; Chiang MC; Fu RH; Lee CW; Huang HR; Tsai MH
    Am J Infect Control; 2014 Jan; 42(1):23-7. PubMed ID: 24176602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
    Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED.
    Kang CI; Chung DR; Peck KR; Song JH;
    Am J Emerg Med; 2012 Sep; 30(7):1169-75. PubMed ID: 22030178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 149.